Skip to main content
Premium Trial:

Request an Annual Quote

Geneart Doubles Tradable Shares with Bonus Stock Issue

NEW YORK (GenomeWeb News) – Gene synthesis firm Geneart said Friday that it planned to issue bonus shares in a 1:1 ratio in order to double its number of tradable shares. 
 
Geneart, based in Regensburg, Germany, is listed on the German Stock Exchange.
 
The company said that the issue of bonus shares is comparable to a 1:1 stock split. It doubles the number of shares for each account, while the price of each share is halved.
 
Geneart said that the bonus shares raise its subscribed capital from €2.2 million to €4.4 million.
 
Christian Ehl, CFO of Geneart, said in a statement that the company decided to increase its tradable shares “to support the liquidity and tradability” of its stock.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.